Stimulation of human and rat islet β-cell proliferation with retention of function by the homeodomain transcription factor Nkx6.1

Molecular and Cellular Biology

Volumn 28, Issue 10, 2008, Pages 3465-3476

  Schisler, Jonathan C ^a   Fueger, Patrick T ^a   Babu, Daniella A ^b   Hohmeier, Hans E ^a   Tessem, Jeffery S ^a   Lu, Danhong ^a   Becker, Thomas C ^a   Naziruddin, Bashoo ^c   Levy, Marlon ^c   Mirmira, Raghavendra G ^b   Newgard, Christopher B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BROXURIDINE; COMPLEMENTARY DNA; CYCLIN A; CYCLIN B; CYCLIN E; GLUCOSE; THYMIDINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX6.1; TRITIUM;

ANIMAL TISSUE; ARTICLE; CELL CYCLE REGULATION; CELL DIVISION; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INSULIN RELEASE; MICROARRAY ANALYSIS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADENOVIRIDAE; ANIMALS; BASE SEQUENCE; CELL CYCLE; CELL PROLIFERATION; CYCLIN A; CYCLIN B; CYCLINS; DNA PRIMERS; GENE EXPRESSION; GLUCOSE; HOMEODOMAIN PROTEINS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; KINETICS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); RATS; RECOMBINANT PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; TISSUE CULTURE TECHNIQUES;

ADENOVIRIDAE; CYTOMEGALOVIRUS; RATTUS;

EID: 43249122991     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01791-07     Document Type: Article

References (46)

1. 1/S phase transition. Nat. Cell Biol. 7:831-836.
2. Bain, J. R., J. C. Schisler, K. Takeuchi, C. B. Newgard, and T. C. Becker. 2004. An adenovirus vector for efficient RNA interference-mediated suppression of target genes in insulinoma cells and pancreatic islets of langerhans. Diabetes 53:2190-2194.
3. Beattie, G. M., A. M. Montgomery, A. D. Lopez, E. Hao, B. Perez, M. L. Just, J. R. Lakey, M. E. Hart, and A. Hayek. 2002. A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes 51:3435-3439.
4. Becker, T. C., R. J. Noel, W. S. Coats, A. M. Gomez-Foix, T. Alam, R. D. Gerard, and C. B. Newgard. 1994. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43A:161-189.
5. Bernal-Mizrachi, E., W. Wen, S. Stahlhut, C. M. Welling, and M. A. Permutt. 2001. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J. Clin. Investig. 108:1631-1638.
6. Bonner-Weir, S. 2001. Beta-cell turnover: its assessment and implications. Diabetes 50(Suppl. 1):S20-S24.
7. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
8. Chakrabarti, S. K., J. C. James, and R. G. Mirmira. 2002. Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J. Biol. Chem. 277:13286-13293.
9. Chakrabarti, S. K., and R. G. Mirmira. 2003. Transcription factors direct the development and function of pancreatic beta cells. Trends Endocrinol. Metab. 14:78-84.
10. Clark, S. A., C. Quaade, H. Constandy, P. Hansen, P. Halban, S. Ferber, C. B. Newgard, and K. Normington. 1997. Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression. Diabetes 46:958-967.
11. Cozar-Castellano, I., N. Fiaschi-Taesch, T. A. Bigatel, K. K. Takane, A. Garcia-Ocana, R. Vasavada, and A. F. Stewart. 2006. Molecular control of cell cycle progression in the pancreatic beta-cell. Endocr. Rev. 27:356-370.
12. Cozar-Castellano, I., K. K. Takane, R. Bottino, A. N. Balamurugan, and A. F. Stewart. 2004. Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1. Diabetes 53:149-159.
13. de la Tour, D., T. Halvorsen, C. Demeterco, B. Tyrberg, P. Itkin-Ansari, M. Loy, S. J. Yoo, E. Hao, S. Bossie, and F. Levine. 2001. Beta-cell differentiation from a human pancreatic cell line in vitro and in vivo. Mol. Endocrinol. 15:476-483.
14. Del Bene, F., and J. Wittbrodt. 2005. Cell cycle control by homeobox genes in development and disease. Semin. Cell Dev. Biol. 16:449-460.
15. Fatrai, S., L. Elghazi, N. Balcazar, C. Cras-Meneur, I. Krits, H. Kiyokawa, and E. Bernal-Mizrachi. 2006. Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 55:318-325.
16. Garcia-Ocana, A., K. K. Takane, V. T. Reddy, J. C. Lopez-Talavera, R. C. Vasavada, and A. F. Stewart. 2003. Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death. J. Biol. Chem. 278:343-351.
17. Georgia, S., and A. Bhushan. 2004. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J. Clin. Investig. 114:963-968.
18. Georgia, S., and A. Bhushan. 2006. p27 regulates the transition of beta-cells from quiescence to proliferation. Diabetes 55:2950-2956.
19. Habener, J. F., D. M. Kemp, and M. K. Thomas. 2005. Transcriptional regulation in pancreatic development. Endocrinology 146:1025-1034.
20. Hohmeier, H. E., H. BeltrandelRio, S. A. Clark, R. Henkel-Rieger, K. Normington, and C. B. Newgard. 1997. Regulation of insulin secretion from novel engineered insulinoma cell lines. Diabetes 46:968-977.
21. Hohmeier, H. E., and C. B. Newgard. 2005. Islets for all? Nat. Biotechnol. 23:1231-1232.
22. Iype, T., J. Francis, J. C. Garmey, J. C. Schisler, R. Nesher, G. C. Weir, T. C. Becker, C. B. Newgard, S. C. Griffen, and R. G. Mirmira. 2005. Mechanism of insulin gene regulation by the pancreatic transcription factor Pdx-1: application of pre-mRNA analysis and chromatin immunoprecipitation to assess formation of functional transcriptional complexes. J. Biol. Chem. 280:16798-16807.
23. Iype, T., D. G. Taylor, S. M. Ziesmann, J. C. Garmey, H. Watada, and R. G. Mirmira. 2004. The transcriptional repressor Nkx6.1 also functions as a deoxyribonucleic acid context-dependent transcriptional activator during pancreatic β-cell differentiation: evidence for feedback activation of the nkx6.1 gene by Nkx6.1. Mol. Endocrinol. 18:1363-1375.
24. Jensen, J., P. Serup, C. Karlsen, T. F. Nielsen, and O. D. Madsen. 1996. mRNA profiling of rat islet tumors reveals Nkx 6.1 as a beta-cell-specific homeodomain transcription factor. J. Biol. Chem. 271:18749-18758.
25. Jin, P., S. Hardy, and D. O. Morgan. 1998. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol. 141:875-885.
26. Jonas, J. C., A. Sharma, W. Hasenkamp, H. Ilkova, G. Patane, R. Laybutt, S. Bonner-Weir, and G. C. Weir. 1999. Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J. Biol. Chem. 274:14112-14121.
27. Jorgensen, M. C., H. Vestergard Petersen, J. Ericson, O. D. Madsen, and P. Serup. 1999. Cloning and DNA-binding properties of the rat pancreatic beta-cell-specific factor Nkx6.1. FEBS Lett. 461:287-294.
28. Joseph, J. W., V. Koshkin, M. C. Saleh, W. I. Sivitz, C. Y. Zhang, B. B. Lowell, C. B. Chan, and M. B. Wheeler. 2004. Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression. J. Biol. Chem. 279:51049-51056.
29. Kushner, J. A., M. A. Ciemerych, E. Sicinska, L. M. Wartschow, M. Teta, S. Y. Long, P. Sicinski, and M. F. White. 2005. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol. Cell. Biol. 25:3752-3762.
30. Lebovitz, H. E. 2004. Chapter 76, Insulin secretagogues: sulfonylureas, meglitinides, and phenylalanine derivatives, p. 1107-1138. In D. LeRoith, S. I. Taylor, and J. M. Olefsky (ed.), Diabetes mellitus, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, PA.
31. 1 cyclindependent kinase activity in the induction of S phase. Proc. Natl. Acad. Sci. USA 96:6626-6631.
32. Magne, S., S. Caron, M. Charon, M. C. Rouyez, and I. Dusanter-Fourl. 2003. STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression. Mol. Cell. Biol. 23:8934-8945.
33. Milburn, J. L., Jr., H. Hirose, Y. H. Lee, Y. Nagasawa, A. Ogawa, M. Ohneda, H. BeltrandelRio, C. B. Newgard, J. H. Johnson, and R. H. Unger. 1995. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J. Biol. Chem. 270:1295-1299.
34. Mirmira, R. G., H. Watada, and M. S. German. 2000. Beta-cell differentiation factor Nkx6.1 contains distinct DNA binding interference and transcriptional repression domains. J. Biol. Chem. 275:14743-14751.
35. Naber, S. P., J. M. McDonald, L. Jarett, M. L. McDaniel, C. W. Ludvigsen, and P. E. Lacy. 1980. Preliminary characterization of calcium binding in islet-cell plasma membranes. Diabetologia 19:439-444.
36. Ozawa, H., S. Ashizawa, M. Naito, M. Yanagihara, N. Ohnishi, T. Maeda, Y. Matsuda, Y. Jo, H. Higashi, A. Kakita, and M. Hatakeyama. 2004. Paired-like homeodomain protein ESXR1 possesses a cleavable C-terminal region that inhibits cyclin degradation. Oncogene 23:6590-6602.
37. Pedersen, I. L., R. Klinck, J. Hecksher-Sorensen, S. Zahn, O. D. Madsen, P. Serup, and M. C. Jorgensen. 2006. Generation and characterization of monoclonal antibodies against the transcription factor Nkx6.1. J. Histochem. Cytochem. 54:567-574.
38. Qiu, M., K. Shimamura, L. Sussel, S. Chen, and J. L. Rubenstein. 1998. Control of anteroposterior and dorsoventral domains of Nkx-6.1 gene expression relative to other Nkx genes during vertebrate CNS development. Mech. Dev. 72:77-88.
39. Rane, S. G., P. Dubus, R. V. Mettus, E. J. Galbreath, G. Boden, E. P. Reddy, and M. Barbacid. 1999. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat. Genet. 22:44-52.
40. Rudnick, A., T. Y. Ling, H. Odagiri, W. J. Rutter, and M. S. German. 1994. Pancreatic beta cells express a diverse set of homeobox genes. Proc. Natl. Acad. Sci. USA 91:12203-12207.
41. Sander, M., L. Sussel, J. Conners, D. Scheel, J. Kalamaras, F. Dela Cruz, V. Schwitzgebel, A. Hayes-Jordan, and M. German. 2000. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 127:5533-5540.
42. Schisler, J. C., P. B. Jensen, D. G. Taylor, T. C. Becker, F. K. Knop, S. Takekawa, M. German, G. C. Weir, D. Lu, R. G. Mirmira, and C. B. Newgard. 2005. The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells. Proc. Natl. Acad. Sci. USA 102:7297-7302.
43. Tuttle, R. L., N. S. Gill, W. Pugh, J. P. Lee, B. Koeberlein, E. E. Furth, K. S. Polonsky, A. Naji, and M. J. Birnbaum. 2001. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat. Med. 7:1133-1137.
44. Vallstedt, A., J. Muhr, A. Pattyn, A. Pierani, M. Mendelsohn, M. Sander, T. M. Jessell, and J. Ericson. 2001. Different levels of repressor activity assign redundant and specific roles to Nkx6 genes in motor neuron and interneuron specification. Neuron 31:743-755.
45. Weir, G. C., and S. Bonner-Weir. 2004. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53:S16-S21.
46. Zhong, L., S. Georgia, S. I. Tschen, K. Nakayama, and A. Bhushan. 2007. Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic beta cells. J. Clin. Investig. 117:2869-2876.